The missions of FDA and NTP overlap where toxicology data-gaps exist on chemicals/compounds/materials that are regulated by the FDA (1). This interagency agreement is in its 18th year supporting toxicology studies at FDA/NCTR, providing data for FDA and other regulatory agencies to protect the United States public.Provide toxicology data for FDA risk assessment and risk management decisions by the FDA.Meetings were held in May and November 2010 to discuss ongoing studies and newly proposed study designs that are part of the interagency agreement between the FDA and NTP/NIEHS that support the FDA risk-assessment process. The meetings are comprised of regulatory scientists and subject experts from the FDA Centers and ORA, NIEHS, and invited subject-matter experts from other government agencies, industry and academia. Ongoing studies that were discussed include dietary supplements, food contaminants, and medical device components. Newly proposed studies include Oxybenzone and Goldenseal.main1. Communicate NTP studies, programs, and summaries to FDA Centers3/31/2010Completed3/31/2010main2. Establish Working Group on dietary supplements, herbals, and botanicals4/1/2010Completed5/17/2010main3. Establish Working Group on sunscreen monograph (CDER initiative to define toxicity data gaps and coordinate studies with NTP and NCTR) ingredients4/1/2010Completed1/6/2010(1) NTP is an intra-Agency program between the National Institutes of Health (NIH) and NCTR whereby NIH directs the toxicological research and NCTR performs the research.NTPNational Toxicology ProgramNIEHSNational Institute of Environmental Health SciencesCDERCenter for Drug Evaluation and ResearchOxybenzonesunscreenGoldensealdietary supplementNIHNational Institutes for Healthhttp://www.fda.gov/AboutFDA/Transparency/track/ucm203296.htmFDA-TRACK NCTR Dashboardhttp://www.fda.gov/AboutFDA/Transparency/track/ucm252974.htmFDA-TRACK Research Glossary਍††਍਍਍਍਍਍਍